1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Investigación quirúrgica en urología y trasplante renal

Investigación quirúrgica en urología y trasplante renal

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Rizzo A, Myint ZW, Ciccimarra F, Zgura A, Matrana MR, Büttner T, Kopecky J, Vida AR, Rizzo M, Fujita K, Brunetti O, Santini D, Park SH, Formisano L, Poprach A, Kucharz J, Comes MC, Bove S, Fanizzi A, Massafra R, Cazzato G, Monteiro FSM, Mollica V, Massari F, Cerrillo JM, Santoni M.

    Bone metastases in advanced urothelial carcinoma patients receiving enfortumab vedotin: A Real-World study from the ARON-2EV project

    CLINICAL AND EXPERIMENTAL MEDICINE . 26(1): 75-75. Nº de citas: 2

    [doi:10.1007/s10238-025-02020-3]

  • Araujo-Castro M, Donato S, García Sanz I, Mínguez Ojeda C, Hanzu FA, Mora M, Revuelta Sánchez-Vera R, González Boillos M, Abellán Galiana P, Lamas C, López García MC, Del Castillo Tous M, Ruíz Rodríguez M, Barahona San Millán R, Recasens M, Gracia Gimeno P, Robles Lazaro C, Herrero-Ruiz A, Michalopoulou T, Menéndez Torre E, Fernández R, Pérez Castro P, Álvarez-Escolá C, Martín Rojas-Marcos P, García-Centeno R, de Miguel Novoa P, Blanco-Carrera C, Valdés N, Calatayud M, Herrera-Martínez AD.

    Impact of presurgical beta-blockade on surgical outcomes in patients with PPGLs.

    ENDOCRINE-RELATED CANCER . 32(12): .

    [doi:10.1530/ERC-25-0308]

  • Del Giudice F, Santarelli V, Laszkiewicz J, Li S, Krajewski W, Nowak L, Szydelko T, Ferro M, Rocco B, Crocetto F, Barone B, Buonerba C, Contieri R, Pichler R, Subiela JD, Pradere B, Moschini M, Mari A, Mori K, Soria F, Mayr R, Jo JK, Gad M, Challacombe B, Abu-Ghanem Y, Mensah E, Nair R, Thurairaja R, Khan MS, Chung BI.

    The influence of immunocompromised status on recurrence and progression free survival among nonmuscle invasive bladder cancers (NMIBCs) undergoing transurethral resection of bladder tumor (TURBT) and adjuvant intravesical bacillus Calmette Guerin (BCG): Analysis of USA insurance claim data

    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS . 43(12): 6939-69318. Nº de citas: 1

    [doi:10.1016/j.urolonc.2025.07.005]

  • España Navarro R, González-Padilla DA, Subiela JD, Pérez-Serrano C, Olmos D, Carlsson SV.

    Prostate cancer screening

    Asian Journal of Urology . 12(4): 422-433. Nº de citas: 1

    [doi:10.1016/j.ajur.2024.09.003]

  • McLennan S, Verhoeff K, Parente A, Ribano A, Wang Y, Wang Z, Zhou J, Wu X, Chen Y, Sledzinski M, Hellmann A, Raffaelli M, Pennestrì F, Sywak M, Papachristos AJ, Palazzo FF, Sung TY, Kim BC, Lee YM, Eatock F, Anderson H, Iacobone M, Gray D, Chaulk RC, Kosmoliaptsis V, Colucci N, Spiers HVM, Daukša A, Makay O, Turk Y, Atalay HB, Nieveen van Dijkum EJM, Engelsman AF, Holscher I, Materazzi G, Rossi L, Becucci C, Shore SL, Waghorn A, Fung C, Mihai R, Balasubramanian SP, Pannu A, Tatarano S, Velázquez-Fernández D, Miller JA, Serrao-Brown H, Chen Y, Demarchi MS, Djafarrian R, Doran H, Stechman MJ, Perry H, Hubbard J, Lamas C, Mercer P, MacPherson J, Lumbiganon S, Calatayud M, Hanzu FA, Vidal O, Araujo-Castro M, Minguez Ojeda C, Papavramidis T, de Vera Gómez PR, Aldrees A, Altwjry T, Valdés N, Álvarez-Escola C, García Sanz I, Blanco Carrera C, Manjón-Miguélez L, De Miguel Novoa P, Recasens M, Centeno RG, Lázaro CR, Van Den Heede K, Van Slycke S, Michalopoulou T, Aspinall S, Melvin R, Lau JWL, Cheah WK, Tang MH, Oh HB, Ayuk J, Sutcliffe RP.

    Evaluation of the effect of tumour size on outcomes for patients undergoing adrenalectomy for phaeochromocytoma: international multicentre analysis

    BJS Open . 9(6): .

    [doi:10.1093/bjsopen/zraf133]

  • Pichler R, Klinglmair G, Binz K, Grande E, Pirshtuk A, Takeshita H, Ürün Y, Molina-Cerrillo J, Myint ZW, de Liaño AG, Mota A, Salfi A, Fukuokaya W, Sammarco E, Angel M, Kucharz J, Tural D, Fiala O, Rodriguez-Vida A, Morelli F, Poprach A, Safi M, Pinto A, Massari F, Buti S, Gupta S, Monteiro FSM, Soares A, Battelli N, Kanesvaran R, Santoni M.

    Time to metastasis as a prognostic factor in metastatic urothelial carcinoma: results from the ARON-2 study

    CLINICAL & EXPERIMENTAL METASTASIS . 43(1): 1-1.

    [doi:10.1007/s10585-025-10382-x]

  • París-Ogáyar M, Ming L, Zhang F, Ximendes E, Marin R, Lifante-Pedrola G, Serrano A, Espinosa A, Haro-González P, Hernando J, Ruiz-Molina D, Otaegui JR, Roscini C, Jaque D.

    Accurate and Fast Thermal Sensing via Phase-Responsive Nanothermometers and Neural Networks

    NANO LETTERS . 25(46): 16538-16546. Nº de citas: 2

    [doi:10.1021/acs.nanolett.5c04787]

  • Capdevila J, Hernando J, Molina-Cerrillo J, Benavent Viñuales M, Garcia-Carbonero R, Teulé A, Custodio A, Jimenez-Fonseca P, Lopez C, Hierro C, Carmona-Bayonas A, Alonso V, Llanos M, Sevilla I, Garcia-Alvarez A, Alonso-Gordoa T, Gallego Jiménez I, Antón-Pascual B, Modrego Sánchez A, Grande E.

    Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914)

    CLINICAL CANCER RESEARCH . 31(22): 4655-4663. Nº de citas: 4

    [doi:10.1158/1078-0432.CCR-25-2143]

  • Kopp RM, Massari F, Grande E, Schieber TJ, Ürün Y, Kopecký J, Molina-Cerrillo J, Basso U, Kucharz J, Büttner T, Pichler R, Fiala O, Myint ZW, Galli L, Buchler T, Rizzo M, Bolek H, Bourlon MT, Conteduca V, Pinto A, Rizzo A, Rosellini M, Roviello G, Zgura A, Mollica V, Partl A, Yildirim A, Akova U, Buti S, Monteiro FSM, Soares A, Porta C, Bilen MA, Li H, Santoni M.

    Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study

    CANCER IMMUNOLOGY IMMUNOTHERAPY . 74(12): 374-374. Nº de citas: 8

    [doi:10.1007/s00262-025-04230-w]

  • Guerrero-Ramos F, Gómez-Cañizo C, Hernández-Arroyo M, Subiela JD, Pradere B, Xylinas E, Rodríguez-Antolín A.

    Hyperthermic intravesical chemotherapy for Bacillus Calmette-Guérin-unresponsive nonmuscle-invasive bladder cancer

    CURRENT OPINION IN UROLOGY . 35(6): 620-628. Nº de citas: 3

    [doi:10.1097/MOU.0000000000001329]

  • Artiles Medina A, Subiela JD, Pichler R, Guerrero-Ramos F, Burgos Revilla FJ.

    Traditional and next-generation bacillus Calmette-Guérin based treatment strategies for bacillus Calmette-Guérin unresponsive non-muscle-invasive bladder cancer in the era of emerging therapies

    CURRENT OPINION IN UROLOGY . 35(6): 609-619.

    [doi:10.1097/MOU.0000000000001319]

  • Ripollés-Melchor J, Zorrilla-Vaca A, León-Bretscher A, Abad-Motos A, Galán-Menéndez P, Muñoz-Rodés JL, Zapata D, Ramiro-Ruiz Á, Aldecoa C, Molnar V, Jordá-Sanz L, Cuéllar-Martínez A, Berges-Gutiérrez H, Landaluce-Olavarria A, Fernández-García R, Aracil-Escoda N, Pacual-Bellosta AM, Ubré-Lorenzo M, Logroño-Ejea M, Serrano Romero AB, Soriano-Giménez V, Romero-Marcos JM, Nogués-Ramia E, Mugarra-Llopis A, Sánchez-Navas S, Serrat-Puyol J, Orts-Micó FJ, Llácer-Pérez M, Gil-Trujillo S, Alday-Muñoz E, Calero-Lillo A, Gimeno-Fernández P, Sánchez-Martín R, Bustos-García D, Batalla-González A, Chornet MR, Rodríguez-Jiménez R, Anton JF, Jericó-Alba C, Pedregosa-Sanz A, Navarro-Sánchez A, Viñas-Martínez T, Garcia Erce JA, Oriol MP, Abad-Gurumeta A.

    Enhanced recovery after surgery and long-term oncologic outcomes: Post-hoc analysis of the POWER study.

    Revista espanola de anestesiologia y reanimacion . 72(9): 501926-501926. Nº de citas: 2

    [doi:10.1016/j.redare.2025.501926]

  • Montero-Cruces, Lourdes, Rodriguez-Lecoq, Rafael, Lopez-Menendez, Jose, Sbraga, Fabrizio, Sureda-Barbosa, Jose C., Legarra-Calderon, Juan J., Gracia-Baena, Juan M., Matamala-Adell, Marta, Valderrama-Marcos, Jose F., Gomez-Blasco, Felix, Arce-Ramos, Nuria, Martin-Lopez, Carlos E., Pedraz-Prieto, Alvaro, Macias-Rubio, Diego, La Sota, Enrique Perez-de, Adsuar-Gomez, Alejandro, Garcia-Bouza, Monica, Hubsch, Alejandro Crespo-de, Hernandez-Campos, Jose A., Oyarzabal, Jorge Rivas, Lima-Canadas, Pedro, Urso, Stefano, Salmeron-Menendez, Carlota, Gascon-Garcia-Verdugo, Pilar, Carnero-Alcazar, Manuel.

    Data analysis from the Spanish Registry of Cardiac Surgery (RECC) 2021-2024

    Cirugia Cardiovascular . 32(6): 299-318. Nº de citas: 1

    [doi:10.1016/j.circv.2025.08.002]

  • Longoni M, Scilipoti P, De Angelis M, Zaurito P, Tremolada G, Santangelo A, Simone G, Mastroianni R, Lonati C, Zamboni S, Suardi N, Marcq G, Szostek A, Caño Velasco J, Puentedura AL, Subiela JD, Durán PDO, Slusarczyk A, Karakiewicz PI, Pradere B, Soria F, Gontero P, Rouprêt M, Montorsi F, Salonia A, Briganti A, Moschini M.

    Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre study

    BJU INTERNATIONAL . 136(5): 826-834. Nº de citas: 18

    [doi:10.1111/bju.16780]

  • Guerrero P, González-Merino C, García de Quevedo C, Subiela JD, Sotoca P, Calvo JC, Bueno C, García A, Orejana I, Artiles A, Gajate P.

    Toxicity Profile of New Therapies in Metastatic Urothelial Carcinoma and Its Impact on Treatment Selection.

    Cancers . 17(21): . Nº de citas: 2

    [doi:10.3390/cancers17213523]

  • de Angelis M, Pellegrino F, Scilipoti P, Longoni M, Santangelo A, Subiela JD, Contieri R, Afferi L, Zamboni S, Suardi N, Musi G, Luzzago S, D'Andrea D, Laukhtina E, Soria F, Gontero P, Del Giudice F, Khan MS, Thurairaja R, Roupret M, Grobet-Jeandin E, Baudewyns A, Tanaka H, Matsumoto S, Fujii Y, Proietti F, Simone G, Schulz GB, Pyrgidis N, Ploussard G, Antonelli A, Bertolo R, Roumiguie M, Bajeot AS, Mir MC, Umari P, Teoh J, Wong C, Mertens LS, Pichler R, Mori K, Slusarczyk A, Poyet C, Albisinni S, Aziz A, Volpe A, Shariat S, Pradere B, Karakiewicz P, Resca S, Beatrici E, De Groote R, Mottrie A, Necchi A, Montorsi F, Briganti A, Moschini M.

    Real-world impact of cisplatin-based neoadjuvant chemotherapy on bladder cancer survival: a 20-year study

    WORLD JOURNAL OF UROLOGY . 43(1): 636-636. Nº de citas: 4

    [doi:10.1007/s00345-025-05992-9]

  • Powles T, Hussain SA, Climent MA, Carbonero IG, Molina-Cerrillo J, Puente J, Borrega P, Malik J, Dourthe LM, Jones R, Castellano D, Durán I, Loriot Y, Priyadarshini G, Szabados B, Jamal F, Wang YQ, Kotriwala N, Jackson-Spence F, Ackerman C, Grande E.

    Three versus six cycles of platinum-based chemotherapy followed by avelumab maintenance as first-line treatment for advanced urothelial cancer: the phase II DISCUS trial.

    ANNALS OF ONCOLOGY . 37(2): 250-259. Nº de citas: 10

    [doi:10.1016/j.annonc.2025.10.011]

  • Mandel P, Groener D, Follacchio G, Ürün Y, Bourlon MT, Sabet A, Grünwald F, Tural D, Büttner T, Kopp RM, Taha T, Chun FK, Facchini G, Myint ZW, Seront E, Conteduca V, Quiroga MNG, Aurilio G, Palacios GA, Bögemann M, Roviello G, Matrana MR, Sammarco E, Laguado MIZ, Galli L, Ansari J, Danielli L, Molina-Cerrillo J, Rescigno P, Yazgan SC, Bastos DA, Jazieh AR, Monteiro FSM, Soares A, Massari F, Wenzel M, Capoccetti F, Santoni M.

    177Lu-PSMA vs. cabazitaxel in patients with castration-resistant prostate cancer: Real-world efficacy and safety data from the ARON-3 study

    EUROPEAN JOURNAL OF CANCER . 229: 115789-115789.

    [doi:10.1016/j.ejca.2025.115789]